Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit established in 1986 to advance evidence-based psychedelic therapy and end prohibition. MAPS incubated Lykos Therapeutics (formerly MAPS Public Benefit Corporation) which is leading drug development of MDMA-assisted therapy for PTSD. 

Learn more about Psychedelic Science 2025, June 16–20 at the Colorado Convention Center in Denver, at <a href="http://www.psychedelicscience.org/">www.psychedelicscience.org</a>, and visit <a href="http://www.maps.org/">www.maps.org</a> for information on MAPS Learn more about your ad choices. Visit <a href="https://podcastchoices.com/adchoices">podcastchoices.com/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

#2319 - Rick Doblin

The Joe Rogan Experience

AI Chapters

AI Insights

Reviews